{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:47:49Z","timestamp":1758635269960,"version":"3.41.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:p>Benzodiazepines bind to and act on \u03b11-3 and \u03b15-containing GABA<jats:sub>A<\/jats:sub> receptors. Previous studies suggest that different GABA<jats:sub>A<\/jats:sub> receptor \u03b1-subtypes mediate the various behavioral effects of benzodiazepines, which raises the possibility of combining benzodiazepines with subtype-selective GABA<jats:sub>A<\/jats:sub> receptor antagonists to improve the therapeutic profiles of benzodiazepines. This study examined the GABA<jats:sub>A<\/jats:sub> receptor subtype mediation of the tolerance to midazolam-induced antinociception in rats. Midazolam (3.2 mg\/kg) significantly reduced the locomotion in rats which was prevented by the selective \u03b11-preferring GABA<jats:sub>A<\/jats:sub> receptor antagonist \u03b2-carboline-3-carboxylate-<jats:italic toggle=\"yes\">t<\/jats:italic>-butyl ester (\u03b2CCt) (3.2 mg\/kg). Midazolam increased the paw withdrawal threshold as tested by the von Frey filament assay in the complete Freund\u2019s adjuvant-induced inflammatory pain model in rats, and this effect was not altered by \u03b2CCt or another \u03b11-preferring GABA<jats:sub>A<\/jats:sub> receptor antagonist 3-propoxy-\u03b2-carboline hydrochloride (3PBC). Repeated treatment with midazolam in combination with vehicle, \u03b2CCt or 3PBC (twice daily) for 7\u2009days led to a progressive increase of the ED<jats:sub>50<\/jats:sub> values in the midazolam- and vehicle-treated rats, but not in other rats, suggesting the development of tolerance to midazolam but not to the combination of midazolam with \u03b11-preferring GABA<jats:sub>A<\/jats:sub> receptor antagonists. These results suggest the essential role of the \u03b11-subtype of GABA<jats:sub>A<\/jats:sub> receptors in mediating the development of tolerance to midazolam-induced antinociceptive effects and raise the possibility of increasing therapeutic profiles of benzodiazepines by selectively blocking specific \u03b1-subtypes of GABA<jats:sub>A<\/jats:sub> receptors.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000614","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T10:04:09Z","timestamp":1607421849000},"page":"345-350","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Blockade of \u03b11 subtype GABAA receptors attenuates the development of tolerance to the antinociceptive effects of midazolam in rats"],"prefix":"10.1097","volume":"32","author":[{"given":"Lakeisha A.","family":"Lewter","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalit K.","family":"Golani","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Cook","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Xu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,12,7]]},"reference":[{"key":"R1-20250614","first-page":"197","article-title":"Drugs for insomnia beyond benzodiazepines: pharmacology, clinical applications and discovery.","volume":"70","author":"Atkin","year":"2018","journal-title":"Pharmacol Ther"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1254\/jphs.08094FP","article-title":"The antinociceptive effects of midazolam on three different types of nociception in mice.","volume":"109","author":"Chiba","year":"2009","journal-title":"J Pharmacol Sci"},{"key":"R3-20250614","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00213-004-1987-3","article-title":"Benzodiazepines and heightened aggressive behavior in rats: reduction by GABA(A)\/alpha(1) receptor antagonists.","volume":"178","author":"Gourley","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bcp.2014.12.010","article-title":"GABAA \u03b15 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085.","volume":"93","author":"de Lucas","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.neuropharm.2010.11.026","article-title":"HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain.","volume":"60","author":"Di Lio","year":"2011","journal-title":"Neuropharmacology"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drugalcdep.2015.10.026","article-title":"Antagonism of triazolam self-administration in rhesus monkeys responding under a progressive-ratio schedule: In vivo apparent pA2 analysis.","volume":"158","author":"Fischer","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.brainresbull.2017.03.001","article-title":"Pharmacological and antihyperalgesic properties of the novel \u03b12\/3 preferring GABAA receptor ligand MP-III-024.","volume":"131","author":"Fischer","year":"2017","journal-title":"Brain Res Bull"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1523\/JNEUROSCI.22-09-03765.2002","article-title":"The GABA(A) receptor alpha1 subtype in the ventral pallidum regulates alcohol-seeking behaviors.","volume":"22","author":"Harvey","year":"2002","journal-title":"J Neurosci"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature06493","article-title":"Reversal of pathological pain through specific spinal GABAA receptor subtypes.","volume":"451","author":"Knabl","year":"2008","journal-title":"Nature"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1021\/acschemneuro.6b00447","article-title":"Antinociceptive effects of a novel \u03b12\/\u03b13-subtype selective GABAA receptor positive allosteric modulator.","volume":"8","author":"Lewter","year":"2017","journal-title":"ACS Chem Neurosci"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1124\/jpet.108.145458","article-title":"Discriminative stimulus effects of DOM in rhesus monkeys: antagonism and apparent pA2 analyses.","volume":"328","author":"Li","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/bph.12555","article-title":"Antihyperalgesic effects of imidazoline I(2) receptor ligands in rat models of inflammatory and neuropathic pain.","volume":"171","author":"Li","year":"2014","journal-title":"Br J Pharmacol"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0166-2236(96)80023-3","article-title":"Which GABAA-receptor subtypes really occur in the brain?","volume":"19","author":"McKernan","year":"1996","journal-title":"Trends Neurosci"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/FBP.0b013e3283512c85","article-title":"The role of \u03b11 and \u03b15 subunit-containing GABAA receptors in motor impairment induced by benzodiazepines in rats.","volume":"23","author":"Mili\u0107","year":"2012","journal-title":"Behav Pharmacol"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.1038\/ncomms7803","article-title":"Analgesia and unwanted benzodiazepine effects in point-mutated mice expressing only one benzodiazepine-sensitive GABAA receptor subtype.","volume":"6","author":"Ralvenius","year":"2015","journal-title":"Nat Commun"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1523\/JNEUROSCI.1067-04.2004","article-title":"Requirement of alpha5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice.","volume":"24","author":"van Rijnsoever","year":"2004","journal-title":"J Neurosci"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"40224","DOI":"10.1074\/jbc.R112.386664","article-title":"Structure, function, and modulation of GABA(A) receptors.","volume":"287","author":"Sigel","year":"2012","journal-title":"J Biol Chem"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/npp.2014.91","article-title":"Effects of the trace amine-associated receptor 1 agonist RO5263397 on abuse-related effects of cocaine in rats.","volume":"39","author":"Thorn","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1007\/s00213-015-3983-1","article-title":"Anti-hyperalgesic effects of imidazoline I2 receptor ligands in a rat model of inflammatory pain: interactions with oxycodone.","volume":"232","author":"Thorn","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/WNR.0000000000000959","article-title":"Contribution of the \u03b15 GABAA receptor to the discriminative stimulus effects of propofol in rat.","volume":"29","author":"Wang","year":"2018","journal-title":"Neuroreport"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals.","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T22:05:20Z","timestamp":1749938720000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,7]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000614","relation":{},"ISSN":["0955-8810"],"issn-type":[{"type":"print","value":"0955-8810"}],"subject":[],"published":{"date-parts":[[2020,12,7]]}}}